Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis

Int J Antimicrob Agents. 2006 Aug;28(2):151-3. doi: 10.1016/j.ijantimicag.2006.05.022. Epub 2006 Jul 3.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Abscess / microbiology
  • Abdominal Abscess / mortality
  • Abdominal Abscess / prevention & control*
  • Amoxicillin-Potassium Clavulanate Combination / administration & dosage
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use*
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteroides Infections / drug therapy
  • Bacteroides Infections / microbiology
  • Bacteroides Infections / mortality
  • Bacteroides fragilis / drug effects*
  • Cephamycins / administration & dosage
  • Cephamycins / therapeutic use*
  • Disease Models, Animal
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / mortality
  • Humans
  • Mice
  • Sepsis / microbiology
  • Sepsis / mortality
  • Sepsis / prevention & control*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Cephamycins
  • Amoxicillin-Potassium Clavulanate Combination
  • cefminox